Can We Please Stop Side-Eyeing People's Medication? A Love Letter to GLP-1s (and the Patients Who Take Them)

Sep 16

Okay, gather round, because we need to have a talk. Not a scary talk, more of a "let's all take a breath, sit in a circle, and be normal about this" talk.

Here's the situation: a bunch of our patients have come in for their follow-up appointments lately and said, in one form or another, "So... my sister-in-law made a comment about my Ozempic." Or, "My coworker asked if I was 'cheating.'" Or my personal favorite, delivered with the exhausted energy of someone who has explained this fourteen times: "I told my mom it's for my A1C and she just looked at me like I'd said it was for my aura."

So let's clear something up, loudly and with our whole chests: a lot of the people in our practice taking GLP-1 medications are not taking them to lose ten vanity pounds before a beach trip. They're taking them because their blood sugar has been having main character energy for years and it needed to sit down. They're taking them because their labs said something needed to change, we had a real conversation about options, and this was the right call for their actual body and their actual health. That's it. That's the whole scandal.

GLP-1s Contain Multitudes

Here's what's wild: these medications were not invented as a weight-loss shortcut that some cool doctor discovered could also help diabetes. It's the other way around. GLP-1 receptor agonists - the Ozempics, the Mounjaros, the Trulicitys of the world - started as treatments for type 2 diabetes, helping the body manage insulin and blood sugar more effectively. The weight loss piece showed up as a very welcome bonus, and once researchers noticed it, they went looking for what else these medications might be quietly good at. Turns out: a lot.

We're now seeing real, growing evidence that GLP-1s can help with things far outside the "shrink the number on the scale" conversation, including:

Blood sugar and A1C control for people with type 2 diabetes — the original job these medications were built for, and still one of the most important.
Cardiovascular risk reduction — semaglutide is FDA-approved specifically to lower the risk of major heart events like heart attack and stroke in people with existing heart disease, whether or not weight loss is even part of the goal.
Kidney protection in people with type 2 diabetes and chronic kidney disease, where these medications have been shown to slow disease progression.
Obstructive sleep apnea — tirzepatide is now FDA-approved to treat moderate-to-severe OSA in patients with obesity, which is a genuinely huge deal for people who've spent years exhausted and were told "just lose weight" as if that were a lever anyone can pull on command.
Liver health, including early but promising research on MASH (that's the condition we used to call NAFLD/NASH), where fat buildup in the liver can lead to serious complications down the road.
Ongoing research into PCOS-related insulin resistance, joint pain from inflammation, and even some early conversations around cravings and impulse control.

Basically, this class of medication is turning out to be the overachiever cousin who was quietly getting a master's degree in something else while everyone assumed she was just really into brunch.

The Shame Spiral Nobody Asked For

And yet. Despite all of this, despite the actual science, the actual lab values, the actual medical practitioner (us! hi!) sitting across from our patients saying "this is a good option for your health" — there is a whole cultural side-eye happening. Research is now catching up to what our patients have been telling us in exam rooms for a while: people, especially women, using GLP-1 medications report real stigma. Friends assume it's vanity. Family members make comments about "the easy way out." Some studies have found that people using these medications are judged more harshly than people who lose weight through diet and exercise alone — as if there's a secret rulebook where some medical treatments count as "earning it" and others don't, a pattern researchers are now formally calling "treatment-related stigma". One recent study even found most patients hide their treatment from people in their lives entirely, which, respectfully, is exhausting and unnecessary and not how healthcare should feel.

Nobody whispers about someone's statin. Nobody side-eyes a person for taking blood pressure medication instead of "just meditating harder." We don't make people justify their asthma inhaler. But a medication for blood sugar and metabolic health gets treated like a moral failing because it happens to also affect weight, a symptom of a much bigger, much more interesting story about how bodies actually work.

Here's the Actual Deal

There is no shortcut prize being unfairly claimed here. Managing A1C, protecting your heart, protecting your kidneys, sleeping through the night without your airway staging a protest — those are health outcomes. Full stop. If a patient and their provider look at labs, history, and goals, and land on a GLP-1 as part of the plan, that is exactly what good medicine is supposed to look like: personalized, evidence-based, and nobody else's business unless the patient chooses to share it.

So if you're one of our patients getting comments from well-meaning (or not-so-well-meaning) people in your life, here is your permission slip to respond however feels right to you, whether that's a full explanation, a cheerful "it's between me and my doctor," or simply changing the subject to something juicier, like the neighbor's suspicious new landscaping. You do not owe anyone your chart.

A Quick Word on Where These Medications Actually Come From

While we're clearing things up, here's another one: not all GLP-1s are created equal, and not all sources are, shall we say, invited to this party. There has been a real gray-market boom of compounded and overseas "peptide" versions of these medications — sold through sketchy websites, spas, and social media ads promising the same results for a fraction of the price. The FDA has sent warning letters to more than fifty of these compounders and manufacturers, moved to restrict the ingredients used in mass-marketed compounded GLP-1s, and flagged well over a thousand adverse event reports tied to unapproved and counterfeit versions — think wrong dosing, contamination, and products that were never actually tested for safety or effectiveness in the first place.

We want to be very clear: that is not what we do here. Our standard of care means we prescribe FDA-approved GLP-1 medications, sourced through legitimate pharmacies, full stop. We're not interested in the version that showed up in someone's Instagram ad from a warehouse we've never heard of, and we'd rather have an honest conversation with you about cost, insurance, and access than quietly look the other way while you order something unregulated off the internet. If cost is the barrier, tell us — that's a real conversation worth having. Your safety is not the place we cut corners.

And if you're someone who's been quietly judging a friend, a sister, a coworker for "taking the easy way" - consider this your gentle nudge to redirect that energy into literally anything else. Compliment her sleep schedule. Ask about her cholesterol. Mind your business with love.

We see you, we see your labs, and we are always, always on your team.

As always, this post is for general information and isn't a substitute for personalized medical advice. If you have questions about whether a GLP-1 medication is right for you, talk with your provider — that's what we're here for.

Further reading / sources:

Liz Meyer

Can We Please Stop Side-Eyeing People's Medication? A Love Letter to GLP-1s (and the Patients Who Take Them)

Perimenopause: Now Arriving